|
Market Closed -
NSE India S.E.
04:35:07 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,423.50 INR | +0.25% |
|
-0.61% | -5.81% |
| 25/08 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
| 14/08 | Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.2TCr | |||||
| 4.82TCr | |||||
| 4TCr | |||||
| 1.24TCr | |||||
| 934.62Cr | |||||
| 775.13Cr |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
